ŌURA account plan
Sleep and activity tracking
At a glance
Oura makes the Oura Ring smart ring and its health membership: approximately $1.75 billion revenue in fiscal 2026 and over six million members.
Oura (Oura Inc.) is an always-on health intelligence platform anchored by Oura Ring, the world's smallest smart ring, sold with a paid membership in the Oura App that turns sleep, activity, stress, heart, metabolic and women's health signals into more than 50 metrics. Founded in Finland in 2013, it is headquartered in San Francisco with E.U. headquarters in Oulu, and redomiciled to a Delaware parent on March 31, 2026. Preliminary, unaudited fiscal 2026 revenue (year to Sept. 30) was approximately $1.75 billion, up 92 percent, after $907.9 million in fiscal 2025; it counted about 1,350 full-time employees across 11 countries at June 30, 2026. Venture-backed (Series E at $53.57 per share in September 2025), it filed an S-1 in September 2026 for a Nasdaq listing under the ticker OURA.
Business units
Hardware (Oura Ring)
approximately 80% of revenue in the nine months ended June 30, 2026 ($974.0 million)Sales of Oura Ring and accessories through direct-to-consumer and wholesale channels (Amazon, Best Buy, Costco, Harrods, Target; about 8,400 retail doors). Rings Sold grew from 1.8 million to 3.1 million in the nine months; Oura Ring 5 launched on June 4, 2026 at starting MSRPs of $399 to $499. Less than 20% of hardware revenue is generated outside the United States.
Membership
approximately 20% of revenue in the nine months ended June 30, 2026 ($240.5 million)Paid membership in the Oura App at $5.99 per month or $69.99 per year in the US, with an 89% gross margin in the nine months and revenue growth of 121%. Features include Health Radar, Meals, Health Panels lab tests and the Oura Advisor AI companion; Weighted-Average 12-Month Paid Member Retention is approximately 85%.
Strategic priorities
- Moving from wellness into healthcare
- CEO Tom Hale says Oura is "already in the health care business": it has FDA approval for the Fertile Window and expects to provide information used in clinical settings. The $625 million cash acquisition of Counsel Health adds medical AI and board-certified physicians inside the Oura App across preventive, acute, and specialty and chronic care.
- Gaining share of the wearables market
- Oura sold 3.6 million rings in the 12 months ended June 30, 2026, approximately 2% of the 212 million wearables shipped globally; U.S. aided brand awareness rose from about 15% to about 38%. Hale argues share gains alone can double or triple the business.
- International expansion
- Oura plans to enter underpenetrated markets with a localized go-to-market, using DTC demand signals before scaling through retail partners and broader marketing.
- Enterprise, employer and healthcare channels
- Oura is developing enterprise, employer and healthcare channels, including subsidized or employer-sponsored adoption; partners include the Defense Health Agency, Medicare Advantage provider Essence, LillyDirect, Resmed and Dexcom.
- AI and new product capabilities
- Proprietary health foundation models, domain models and custom health LLMs power Oura Advisor; Hale plans new sensing, a faster hardware cadence and Health Radar predictions across more health domains.
Latest results
For the fiscal fourth quarter ended Sept. 30, 2026, Oura reported preliminary, unaudited revenue of $533 million, up 153 percent year over year, with $87 million of Adjusted EBITDA, a 16 percent margin, and gross margin expanding year over year. Fiscal year 2026 revenue was approximately $1.75 billion, 92 percent growth. Over the nine months ended June 30, 2026, revenue was $1,214.5 million, up 74%, with net income of $60.8 million and Adjusted EBITDA of $106.7 million. Executive Chairman David Shuman cites over six million members.
Investments and deals
- Counsel Health acquisition
- Definitive agreement to acquire AI-native primary care company Counsel Health for $625 million in cash, subject to purchase price adjustments, expected to close before the end of the calendar year; Counsel keeps serving health plans, health systems and employers.
- IPO preparation and capital structure
- The S-1 offered 50,000,000 shares at $40.00 to $44.00, of which 13,500,000 by Oura; most of Oura's estimated $532.6 million net proceeds was earmarked for RSU net settlement taxes. Oura raised about $908 million in its Series E (September 2025) and expanded its revolving credit facility to $525.0 million.
- San Francisco headquarters
- Oura bought a building of about 47,000 square feet in San Francisco in July 2026 for its headquarters.
Challenges and risks
- Warranty costs on Oura Ring 4
- Battery performance issues on certain Oura Ring 4 cohorts raised warranty expense by $84.4 million in fiscal 2025 and may keep adding near-term gross margin variability.
- Supply chain and tariffs
- Oura relies on a limited number of contract manufacturers and single- or limited-source suppliers, and faces tariffs on products and components made in Estonia, Finland, Mexico, South Korea, China and the Netherlands.
- Patent and equity litigation
- Samsung filed an ITC complaint on December 12, 2025 alleging infringement of four patents and seeking import restrictions; Omni MedSci seeks approximately $120 million; former CEO Harpreet Singh Rai and Peter Attia bring equity claims.
- Competition and regulation
- Oura competes with Apple, Google (including Fitbit), Samsung, Coros, Garmin and Whoop, and health features may be regulated as medical devices under the FDA and the EU MDR.
What leadership says
“The subscription isn't like an add-on that gives you extra value. The subscription is the business model”
“We're already in the health care business”
“Over the past 10 years, our ring has gotten smaller and our platform has gotten bigger”
Where a supplier can help
- Clinical-grade care integration
- The move into healthcare and the Counsel Health acquisition create needs in clinical workflow integration, medical records connectivity, regulatory compliance and physician operations inside the Oura App.
- Enterprise and payer distribution
- Developing employer, health plan and government channels calls for partners in benefits distribution, enterprise sales enablement and outcomes measurement.
- Supply chain resilience
- Reliance on limited contract manufacturers and single-source suppliers, tariff exposure and Oura Ring 4 warranty costs point to opportunities in sourcing diversification, quality assurance and reliability testing.
- Localized international launch
- With less than 20% of hardware revenue outside the United States, international expansion needs retail partnerships, localization, logistics and regional marketing support.
- Privacy and security for health data
- A privacy-first model, HIPAA- and GDPR-aligned practices and DoD cybersecurity requirements (NIST SP 800-171) make security, compliance and data-governance tooling relevant.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like ŌURA?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Oura to Acquire Counsel Health, Advancing Vision for More Connected, Personalized Healthcare (with preliminary fiscal Q4 and FY2026 results)
- Oura signed a definitive agreement to acquire Counsel Health, an AI-native primary care company, for $625 million in cash, subject to purchase price adjustments; closing is expected before the end of the calendar year.
- Preliminary, unaudited results for the fiscal fourth quarter ended Sept. 30, 2026: revenue grew 153 percent year over year to $533 million, and Adjusted EBITDA was $87 million, a 16 percent margin; gross margin expanded year over year.
- Fiscal year 2026 revenue was approximately $1.75 billion, 92 percent year-over-year growth (preliminary, subject to the year-end close and audit).
- Oura counts over six million members (Executive Chairman David Shuman).
- Counsel combines medical AI with in-house, board-certified physicians inside the Oura App; the companies will build on their existing partnership across preventive, acute, and specialty and chronic care.
- Counsel will keep serving its enterprise partners (health plans, health systems, consumer health organizations and employers), opening the door to people beyond Oura's member base.
- CEO Tom Hale calls the deal a massive step towards "a 24-7 doctor in your pocket"; Shuman says it "expands our addressable market" and increases lifetime value.
- Vlad Tenev (Robinhood) interviews Oura CEO Tom Hale ahead of the IPO (transcript filed as a free writing prospectus)
- Hale frames Oura as "a health intelligence platform", not a ring company, and health as a far more durable and larger market than fitness, which he calls "a churny use case".
- Scale: Oura was "probably a $150 million business" when he joined in 2022 and has "done $1.4 billion in the last twelve months", roughly doubling each year; five million paid members, up 100% year over year.
- The subscription "is the business model": 85% paid-member retention at one year, DAU/MAU he calls "off the charts", members open the app three times a day.
- Growth drivers: word of mouth is about 40% of customer acquisition, "which we get for free", plus rising awareness of what a smart ring does (illness prediction, ovulation tracking).
- Moat: finger signal two orders of magnitude stronger than the wrist, seven-day battery, over 1,100 patents used "both as a sword and a shield", a faster hardware cadence.
- The ring is "the hub" of a future "cloud of wearables"; Oura is vertically integrated from sensor to AI interpretation (Oura Advisor).
- Next: Oura Ring 5 (launched June, 40% smaller), new sensing and possibly payments/keys, Health Radar predictions; long term, transforming how care is delivered.
- Oura Inc. Registration Statement on Form S-1, Amendment No. 1 (preliminary IPO prospectus)
- Oura is an always-on health intelligence platform anchored by Oura Ring, the world's smallest smart ring, with 5.0 million Paid Members in 56 markets as of June 30, 2026; founded in Finland in 2013, redomiciled to a Delaware parent (Oura Inc.) on March 31, 2026, HQ San Francisco.
- Revenue $907.9 million in fiscal 2025 (year to September 30), up 123%; $1,214.5 million in the nine months ended June 30, 2026, up 74%; net income $60.8 million and Adjusted EBITDA $106.7 million for the nine months.
- Two revenue streams, one reportable segment: Hardware (80% of nine-month revenue, $974.0 million) and Membership (20%, $240.5 million, 89% gross margin, $5.99 per month or $69.99 per year in the US).
- US-centric: less than 20% of hardware revenue generated outside the United States; approximately 49% of hardware revenue through retail (Amazon, Best Buy, Costco, Harrods, Target), about 8,400 retail doors.
- Growth strategy: increase penetration (approximately 2% of 212 million wearables shipped), expand into new geographies, launch products (Oura Ring 5 launched June 4, 2026), expand the partner network (1,200 partners), and develop enterprise, employer and healthcare channels; SAM over $90 billion.
- Retention and engagement: Weighted-Average 12-Month Paid Member Retention approximately 85%, DAU-to-MAU approximately 65%, about 40% of members acquired organically.
- Risks: Oura Ring 4 battery warranty costs (warranty expense up $84.4 million in fiscal 2025), contract manufacturers and single-source suppliers, tariffs, Samsung ITC patent complaint, regulation of health features, competition from Apple, Google, Samsung, Garmin and Whoop.
- IPO terms: 50,000,000 shares (13,500,000 by Oura) at $40.00 to $44.00 on Nasdaq as OURA; most of Oura's net proceeds ($526.4 million of an estimated $532.6 million) earmarked for RSU net settlement taxes.
- Why Oura is running toward Washington oversight (Semafor Compound Interest with Tom Hale, transcript)
- Hale: "We're already in the health care business"; Oura is moving toward regulated, clinical-grade features (FDA approval for Fertile Window, pursuing blood-pressure clearance) rather than staying in wellness.
- On subscription fatigue: value-over-price matters; Oura retains better at 12 and 24 months than Spotify and Netflix, and north of 50% of subscribers pick the annual plan ($70 vs $6 a month).
- Market: wearables are about 200 million devices a year and Oura is "between 1 and 2%" of it, so doubling or tripling only requires share gains; valuation was $11 billion about a year earlier and revenue has "probably doubled" since.
- Margins: blended hardware plus software margins are "more in that ballpark" of apps (60s), funding R&D that discounting no-subscription rivals (Samsung, RingConn) cannot match.
- Redomiciled to Delaware to be a global company; employees are 50/50 Finland and the US; denied IPO prep at the time ("we talk to banks all the time").
- Military and insurers: Defense Health Agency deal against clinician burnout; Medicare Advantage provider Essence gives rings to beneficiaries; data is never sold or shared without consent.
- About one in four members has a chronic illness (the best-retaining cohort) and about 11% come from households under $50,000; demand is for rings that "do more things", not a cheaper model.
Questions about ŌURA
What does Oura do?
Oura makes Oura Ring, a smart ring that tracks more than 50 health metrics, and sells a paid membership in the Oura App with personalized insights across sleep, activity, stress, heart, metabolic and women's health.
What is Oura's revenue?
Preliminary, unaudited fiscal 2026 revenue (year to Sept. 30) was approximately $1.75 billion, up 92 percent; fiscal 2025 revenue was $907.9 million.
How many employees does Oura have?
About 1,350 full-time employees across 11 countries as of June 30, 2026, mainly in California and Finland.
Who leads Oura?
Tom Hale is Chief Executive Officer and David Shuman is Executive Chairman; Sean Brecker is CFO and Michael A. Chapp is COO.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)